Identification of Prognostic Immunophenotypes at First Diagnosis in Patients with Acute Myeloid Leukemia (AML) By a Standardized Multicolor Flow Cytometry (MFC) Panel Originally Designed to Detect Measurable Residual Disease (MRD) at Follow-up

Aims In AML, several risk factors obtained at first diagnosis (FD) have been reported to be associated with shorter RFS and OS. The primary prognostic relevance of multicolour flow cytometry (MFC) has been a matter of debate for years. During follow-up (FU), the prognostic relevance of MRD as detect...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2020-11, Vol.136 (Supplement 1), p.35-35
Hauptverfasser: Rohnert, Maximilian Alexander A, von Bonin, Malte, Kramer, Michael, Ensel, Philipp, Holtschke, Nadja, Rollig, Christoph, Bornhäuser, Martin, Buecklein, Veit, Subklewe, Marion, Krause, Stefan W, Voelkl, Simon, Berg, Tobias, Rieger, Michael A, Brendel, Cornelia, Hoffmann, Jörg, Hofmeister-Mielke, Nicole, Schlenk, Richard F., Freeman, Sylvie D, Oelschlägel, Uta
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!